Skip to main content
CannAmerica Brands Corp. logo

CannAmerica Brands Corp. — Investor Relations & Filings

Ticker · CNNXF ISIN · CA13766C1005 CSE Administrative and support service activities
Open in API
Filings indexed 132 across all filing types
Latest filing 2022-06-25 Board/Management Inform…
Country CA Canada
Listing CSE CNNXF

About CannAmerica Brands Corp.

http://cannamericabrands.com/

CannAmerica Brands Corp. owns and operates a portfolio of medical and recreational cannabis brands. The company's primary business model centers on building, enhancing, and monetizing the global reach of its brands through strategic licensing agreements with qualified partners. These licensees are selected based on their ability to cultivate, manufacture, and produce the branded products. CannAmerica's product portfolio includes various recreational cannabis products, notably a line of flavored gummies (such as peach, blueberry, and strawberry). Founded and operated by a U.S. Marine veteran, the company focuses on expanding its brand presence across licensed jurisdictions in the United States and Canada. It also maintains a separate CannAmerica Clothing Division and e-commerce platform.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Board/Management Information Classification · 95% confidence The document is a company announcement regarding the unexpected passing of the founder, President, and CEO of CannAmerica Brands Corp. It provides biographical information about the deceased and mentions the company's intention to search for a successor. There is no financial data, no mention of a report or filing, no regulatory or legal proceedings, no voting results, no capital or financing updates, and no other specific corporate actions. The document is a general corporate announcement about management changes due to the death of a key executive. This fits best under Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2022-06-25 English
News release - English.pdf
Regulatory Filings
2022-05-11 English
Interim MD&A - English.pdf
Management Reports Classification · 95% confidence The document is titled 'Management’s Discussion and Analysis for the Period Ended December 31, 2021' and contains detailed narrative about the company's business operations, licensing agreements, revenue sources, and strategic plans. It references financial statements and notes for the quarter ended December 31, 2021, indicating it is a comprehensive management discussion and analysis (MD&A) report. The document length is substantial (15,000 characters), and it contains substantive financial and operational information rather than just an announcement or certification. Therefore, it fits the category of Management Reports (MDA), which provide detailed explanations of financial results, business trends, and outlook. It is not an Annual Report (10-K) or Interim Report (IR) because it specifically identifies itself as MD&A and focuses on management's discussion rather than full financial statements. Hence, the correct classification is MDA with high confidence.
2022-03-01 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Consolidated Financial Statements For the Three Months Ended December 31, 2021' and contains detailed unaudited financial statements including statements of financial position, operations, changes in deficiency, cash flows, and notes to the consolidated financial statements. It explicitly states it is an interim report for a three-month period ending December 31, 2021. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement. The presence of comprehensive financial data and notes confirms it is a substantive financial report for a period shorter than a full fiscal year. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q3 2022
2022-03-01 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification statement by the CFO regarding the interim financial report and interim MD&A for the period ended December 31, 2021. It is a Form 52-109FV2, which is a certification of interim filings for a venture issuer. The text does not contain actual financial data or substantive financial analysis but rather attests to the accuracy and fair presentation of the interim filings. According to the Certification Rule, documents that are primarily officer certifications or attestations, even if referencing interim reports, should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (3006 characters), and it is clearly a certification letter, not the interim report or MD&A itself.
2022-03-01 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification statement by the CEO regarding the interim financial report and interim MD&A for the period ended December 31, 2021. It is a Form 52-109FV2 Certification of Interim Filings for a Venture Issuer. The text does not contain the actual interim financial statements or substantive financial data but is a certification attesting to the accuracy and fair presentation of those filings. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than the interim report itself (IR). The document length is short (3000 characters), and it is clearly a certification, not the full interim report.
2022-03-01 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.